Stock Analiz

Dianthus Therapeutics, Inc. (DNTH) stock forecast and price target

Price $91.81 · data as of November 13, 2026

12-month price target

Average target$139.25
Upside / downside+51.7%
Analysts16
ConsensusStrong buy
Low $113.00Average $139.25High $200.00

Gold marker: average target · white marker: today’s price ($91.81)

Analyst ratings

Strong buy 1Buy 17Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-3.60+14.3%$3M
Next fiscal year
ends December 31, 2027
$-4.35−20.8%$2M
Next quarter
ends December 31, 2026
$-0.99+30.5%$339050
Quarter after
ends March 31, 2027
$-1.03−21.5%$460280

Consensus of the analysts covering Dianthus Therapeutics, updated daily. In the last 30 days 4 estimates were raised and 0 lowered.

Frequently asked questions

What is the Dianthus Therapeutics stock price target?

The average 12-month target from 16 analysts is $139.25, 51.7% above the current price of $91.81 Targets range from $113.00 to $200.00.

Is Dianthus Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 17 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Dianthus Therapeutics expected to earn?

Analysts expect EPS of $-3.60 for the fiscal year ending December 31, 2026 and $-4.35 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.